Sponsor Pipeline

Clinique de Retine de l'est Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07129239 High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD)… Wet Age-related Macular Degeneration (wAMD) Not Yet Recruiting
Get alerts when Clinique de Retine de l'est's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free